Common Contracts

61 similar Lease contracts by Cue Health Inc., Erasca, Inc., Oncorus, Inc., others

LEASE by and between 3 VDG Owner LLC, a Delaware limited liability company and Fractyl Health, Inc., a Delaware corporation
Lease • December 14th, 2023 • Fractyl Health, Inc. • Surgical & medical instruments & apparatus

THIS LEASE (this “Lease”) is entered into as of August 10, 2022 (the “Execution Date”), by and between 3 VDG Owner LLC, a Delaware limited liability company (“Landlord”), and Fractyl Health, Inc., a Delaware corporation (“Tenant”).

AutoNDA by SimpleDocs
LEASE by and between BMR-ATHENA LP, a Delaware limited partnership and TURNSTONE BIOLOGICS CORP., a Delaware corporation
Lease • May 15th, 2023 • Turnstone Biologics Corp. • Biological products, (no disgnostic substances)

THIS LEASE (this “Lease”) is entered into as of this 23rd day of [June], 2021 (the “Execution Date”), by and between BMR-ATHENA LP, a Delaware limited partnership (“Landlord”), and TURNSTONE BIOLOGICS CORP., a Delaware corporation (“Tenant”).

LEASE by and between B9 LS HARRISON & WASHINGTON LLC, a Delaware limited liability company and MONTE ROSA THERAPEUTICS, INC., a Delaware corporation
Lease • March 29th, 2022 • Monte Rosa Therapeutics, Inc. • Biological products, (no disgnostic substances)

THIS LEASE (this “Lease”) is entered into as of this 14th day of December, 2021 (the “Execution Date”), by and between B9 LS HARRISON & WASHINGTON LLC, a Delaware limited liability company with offices located at 4570 Executive Drive, Suite 400, San Diego, California 92121 (“Landlord”), and MONTE ROSA THERAPEUTICS, INC., a Delaware corporation, with offices located at 645 Summer Street, Suite 102, Boston, Massachusetts 02210 (“Tenant”).

LEASE by and between BMR-HAMPSHIRE LLC, a Delaware limited liability company and SURFACE ONCOLOGY, INC., a Delaware corporation
Lease • October 4th, 2021 • CM Life Sciences III Inc. • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 13th day of May, 2016 (the “Execution Date”), by and between BMR-HAMPSHIRE LLC, a Delaware limited liability company (“Landlord”), and SURFACE ONCOLOGY, INC., a Delaware corporation (“Tenant”).

LEASE by and between B9 LS HARRISON & WASHINGTON LLC, a Delaware limited liability company and PYXIS ONCOLOGY, INC., a Delaware corporation
Lease • October 1st, 2021 • Pyxis Oncology, Inc. • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 29th day of September, 2021 (the “Execution Date”), by and between B9 LS HARRISON & WASHINGTON LLC, a Delaware limited liability company (“Landlord”), and PYXIS ONCOLOGY, INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-MODA SORRENTO LP, a Delaware limited partnership, AS LANDLORD and CUE HEALTH INC., a Delaware corporation, AS TENANT
Lease • September 1st, 2021 • Cue Health Inc. • Laboratory analytical instruments

THIS LEASE (this “Lease”) is entered into as of this 4th day of December, 2018 (the “Execution Date”), by and between BMR-MODA SORRENTO LP, a Delaware limited partnership (“Landlord”), and CUE HEALTH INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-325 VASSAR STREET LLC, a Delaware limited liability company and OMEGA THERAPEUTICS, INC. a Delaware corporation
Lease • July 26th, 2021 • Omega Therapeutics, Inc. • Biological products, (no disgnostic substances)

THIS LEASE (this “Lease”) is entered into as of this 30th day of November, 2017 (the “Execution Date”), by and between BMR-325 Vassar Street LLC, a Delaware limited liability company (“Landlord”), and Omega Therapeutics, Inc., a Delaware corporation (“Tenant”).

LEASE by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership and ERASCA, INC., a Delaware corporation
Lease • June 25th, 2021 • Erasca, Inc. • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 27th day of July, 2018 (the “Execution Date”), by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership (“Landlord”), and ERASCA, INC., a Delaware corporation (“Tenant”).

LEASE
Lease • May 28th, 2021 • Codex DNA, Inc. • Laboratory analytical instruments

THIS LEASE (this “Lease”) is entered into as of this 04th day of April, 2019 (the “Execution Date”), by and between BMR-WAPLES LP, a Delaware limited partnership (“Landlord”), and SGI-DNA, INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership and ERASCA, INC., a Delaware corporation
Lease • May 7th, 2021 • Erasca, Inc. • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 27th day of July, 2018 (the “Execution Date”), by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership (“Landlord”), and ERASCA, INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-MODA SORRENTO LP, a Delaware limited partnership, AS LANDLORD and CUE HEALTH INC., a Delaware corporation, AS TENANT
Lease • April 19th, 2021 • Cue Health Inc. • Laboratory analytical instruments

THIS LEASE (this “Lease”) is entered into as of this 4th day of December, 2018 (the “Execution Date”), by and between BMR-MODA SORRENTO LP, a Delaware limited partnership (“Landlord”), and CUE HEALTH INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-ONE RESEARCH WAY LLC, a Delaware limited liability company and PMV PHARMACEUTICALS, INC., a Delaware corporation
Lease • March 3rd, 2021 • PMV Pharmaceuticals, Inc. • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 8th day of January, 2021 (the “Execution Date”), by and between BMR-ONE RESEARCH WAY LLC, a Delaware limited liability company (“Landlord”), and PMV PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-500 FAIRVIEW AVENUE LLC, a Delaware limited liability company and SILVERBACK THERAPEUTICS, INC., a Delaware corporation 500 Fairview Avenue North, Seattle, Washington
Lease • November 10th, 2020 • Silverback Therapeutics, Inc. • Pharmaceutical preparations

THIS LEASE (this “Lease”) “is entered into as of this 8th day of June, 2016 (the “Execution Date”), by and between BMR-500 FAIRVIEW AVENUE LLC, a Delaware limited liability company (“Landlord”), and SILVERBACK THERAPEUTICS, INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-HAMPSHIRE LLC, a Delaware limited liability company and ONCORUS, INC., a Delaware corporation
Lease • September 11th, 2020 • Oncorus, Inc. • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 10th day of May, 2016 (the “Execution Date”), by and between BMR-HAMPSHIRE LLC, a Delaware limited liability company (“Landlord”), and ONCORUS, INC., a Delaware corporation (“Tenant”).

LEASE by and between VENTAS BECKLEY, LLC a Delaware limited liability company and GRAYBUG VISION, INC. a Delaware corporation
Lease • September 4th, 2020 • Graybug Vision, Inc. • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 8 day of October, 2019 (the “Effective Date”), by and between VENTAS BECKLEY, LLC, a Delaware limited liability company (“Landlord”), and GRAYBUG VISION, INC., a Delaware corporation (“Tenant”).

LEASE
Lease • July 10th, 2020 • Zentalis Pharmaceuticals, Inc. • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 12th day of November, 2015 (the “Execution Date”), by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership (“Landlord”), and ZENO PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-134 COOLIDGE AVENUE LLC, a Delaware limited liability company and PANDION THERAPEUTICS, INC., a Delaware corporation
Lease • June 26th, 2020 • Pandion Therapeutics Holdco LLC • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 6th day of February, 2020 (the “Execution Date”), by and between BMR-134 COOLIDGE AVENUE LLC, a Delaware limited liability company (“Landlord”), and PANDION THERAPEUTICS, INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-134 COOLIDGE AVENUE LLC, a Delaware limited liability company and PANDION THERAPEUTICS, INC., a Delaware corporation
Lease • May 22nd, 2020 • Pandion Therapeutics Holdco LLC • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 6th day of February, 2020 (the “Execution Date”), by and between BMR-134 COOLIDGE AVENUE LLC, a Delaware limited liability company (“Landlord”), and PANDION THERAPEUTICS, INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership and ZENO PHARMACEUTICALS, INC., a Delaware corporation
Lease • March 6th, 2020 • Zentalis Pharmaceuticals, LLC • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 12th day of November, 2015 (the “Execution Date”), by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership (“Landlord”), and ZENO PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership and ZENO PHARMACEUTICALS, INC., a Delaware corporation
Lease • February 14th, 2020 • Zentalis Pharmaceuticals, LLC • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 12th day of November, 2015 (the “Execution Date”), by and between BMR-ROAD TO THE CURE LP, a Delaware limited partnership (“Landlord”), and ZENO PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-134 COOLIDGE AVENUE LLC, a Delaware limited liability company and BLEND THERAPEUTICS, INC. a Delaware corporation
Lease • December 23rd, 2019 • Organovo Holdings, Inc. • Biological products, (no disgnostic substances)

THIS LEASE (this “Lease”) is entered into as of this 12th day of December, 2011 (the “Execution Date”), by and between BMR-134 COOLIDGE AVENUE LLC, a Delaware limited liability company (“Landlord”), and BLEND THERAPEUTICS, INC. a Delaware corporation (“Tenant”).

LEASE by and between BMR-HAMPSHIRE LLC, a Delaware limited liability company and ONCORUS, INC., a Delaware corporation
Lease • December 20th, 2019 • Oncorus, Inc. • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 10th day of May, 2016 (the “Execution Date”), by and between BMR-HAMPSHIRE LLC, a Delaware limited liability company (“Landlord”), and ONCORUS, INC., a Delaware corporation (“Tenant”).

AutoNDA by SimpleDocs
LEASE
Lease • November 8th, 2019 • Selecta Biosciences Inc • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 23rd day of July, 2019 (the “Execution Date”), by and between BRE-BMR Grove LLC, a Delaware limited liability company (“Landlord”), and Selecta Biosciences, Inc., a Delaware corporation (“Tenant”).

LEASE by and between BMR-ROGERS STREET LLC, a Delaware limited liability company and CYCLERION THERAPEUTICS, INC. a Massachusetts corporation
Lease • April 2nd, 2019 • Cyclerion Therapeutics, Inc. • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 1st day of April, 2019 (the “Execution Date”), by and between BMR-ROGERS STREET LLC, a Delaware limited liability company (“Landlord”), and CYCLERION THERAPEUTICS, INC., a Massachusetts corporation (“Tenant”).

LEASE by and between BMR-SIDNEY RESEARCH CAMPUS LLC, a Delaware limited liability company and GRITSTONE ONCOLOGY, INC. a Delaware corporation
Lease • July 9th, 2018 • Gritstone Oncology, Inc. • Biological products, (no disgnostic substances)

THIS LEASE (this “Lease”) is entered into as of this 11th day of February, 2016 (the “Execution Date”), by and between BMR-Sidney Research Campus LLC, a Delaware limited liability company (“Landlord”), and Gritstone Oncology, Inc., a Delaware corporation (“Tenant”).

LEASE by and between BMR-BAYSHORE BOULEVARD LP, a Delaware limited partnership and UNITY BIOTECHNOLOGY, INC., a Delaware corporation
Lease • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • California

THIS LEASE (this “Lease”) is entered into as of this 13th day of May, 2016 (the “Execution Date”), by and between BMR-BAYSHORE BOULEVARD LP, a Delaware limited partnership (“Landlord”), and UNITY BIOTECHNOLOGY, INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-ROGERS STREET LLC, a Delaware limited liability company and SYNLOGIC, INC. a Delaware corporation
Lease • March 20th, 2018 • Synlogic, Inc. • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this ____ day of [_______], 2017 (the “Execution Date”), by and between BMR-ROGERS STREET LLC, a Delaware limited liability company (“Landlord”), and SYNLOGIC, INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-PACIFIC RESEARCH CENTER LP, a Delaware limited partnership and SHOTSPOTTER, INC., a Delaware corporation, d/b/a SST, INC.
Lease • May 2nd, 2017 • Shotspotter, Inc • Services-prepackaged software

IN WITNESS WHEREOF, Tenant has executed this Acknowledgment of Term Commencement Date and Term Expiration Date as of the date first written above.

LEASE by and between BMR-PACIFIC RESEARCH CENTER LP, a Delaware limited partnership and SHOTSPOTTER, INC., a Delaware corporation, d/b/a SST, INC.
Lease • March 30th, 2017 • Shotspotter, Inc • Services-prepackaged software

IN WITNESS WHEREOF, Tenant has executed this Acknowledgment of Term Commencement Date and Term Expiration Date as of the date first written above.

LEASE by and between BMR-PACIFIC RESEARCH CENTER LP, a Delaware limited partnership and PROTAGONIST THERAPEUTICS, INC., a Delaware corporation
Lease • March 7th, 2017 • Protagonist Therapeutics, Inc • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 6th day of March, 2017 (the “Execution Date”), by and between BMR-PACIFIC RESEARCH CENTER LP, a Delaware limited partnership (“Landlord”), and PROTAGONIST THERAPEUTICS, INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-AXIOM LP, a Delaware limited partnership and LA JOLLA PHARMACEUTICAL COMPANY, a California corporation
Lease • February 23rd, 2017 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances)
LEASE by and between WEXFORD-UCSC II, LP, a Delaware limited partnership and SPARK THERAPEUTICS, INC.,
Lease • March 14th, 2016 • Spark Therapeutics, Inc. • Biological products, (no disgnostic substances)

New Markets Tax Credits: This building/Project was financed in part with a Federal subsidy called New Markets Tax Credits (NMTC). The NMTC Program was established by Congress in 2000 to spur new or increased investments into operating businesses and real estate projects located in low-income communities. Communities benefit from the jobs associated with these investments, as well as greater access to public facilities, goods, and services. In addition, as the communities develop, they become even more attractive to investors, spurring further investments and revitalization.

LEASE by and between BMR-AXIOM LP, a Delaware limited partnership and IGNYTA, INC., a Delaware corporation
Lease • October 21st, 2015 • Ignyta, Inc. • Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 16th day of October, 2015 (the “Execution Date”), by and between BMR-AXIOM LP, a Delaware limited partnership (“Landlord”), and IGNYTA, INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-MEDICAL CENTER DRIVE LLC, a Delaware limited liability company and REGENXBIO INC., a Delaware corporation
Lease • August 17th, 2015 • REGENXBIO Inc. • Biological products, (no disgnostic substances) • Maryland

THIS LEASE (this “Lease”) is entered into as of this 6th day of March, 2015 (the “Execution Date”), by and between BMR-MEDICAL CENTER DRIVE LLC, a Delaware limited liability company (“Landlord”), and REGENXBIO INC., a Delaware corporation (“Tenant”).

LEASE by and between BMR-675 WEST KENDALL STREET LLC, a Delaware limited liability company and ALNYLAM PHARMACEUTICALS, INC., a Delaware corporation
Lease • August 7th, 2015 • Alnylam Pharmaceuticals, Inc. • Pharmaceutical preparations

IN WITNESS WHEREOF, Tenant has executed this Acknowledgment of Term Commencement Date and Term Expiration Date as of the date first written above.

Time is Money Join Law Insider Premium to draft better contracts faster.